Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as arsenic trioxide and pamidronate, work in different ways
to stop the growth of cancer cells, either by killing the cells or by stopping them from
dividing. Arsenic trioxide and pamidronate may also stop the growth of cancer cells by
blocking some of the enzymes needed for cell growth. Pamidronate may also stop the growth of
cancer cells by blocking blood flow to the cancer. Giving arsenic trioxide together with
pamidronate may kill more cancer cells. This phase I trial is studying the side effects and
best dose of arsenic trioxide and pamidronate in treating patients with advanced solid tumors
or multiple myeloma